# Convalescent Plasma as Adjunct Therapy for COVID-19

> **NCT04873414** · PHASE2,PHASE3 · UNKNOWN · sponsor: **National Institute of Health Research and Development, Ministry of Health Republic of Indonesia** · enrollment: 364 (estimated)

## Conditions studied

- COVID-19

## Interventions

- **BIOLOGICAL:** Convalescent plasma treatment

## Key facts

- **NCT ID:** NCT04873414
- **Lead sponsor:** National Institute of Health Research and Development, Ministry of Health Republic of Indonesia
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-12-01
- **Primary completion:** 2021-10-30
- **Final completion:** 2021-12-31
- **Target enrollment:** 364 (ESTIMATED)
- **Last updated:** 2021-06-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04873414

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04873414, "Convalescent Plasma as Adjunct Therapy for COVID-19". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04873414. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*